These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38737731)

  • 1. The Lung Cancer Prediction Model "Stress Test": Assessment of Models' Performance in a High-Risk Prospective Pulmonary Nodule Cohort.
    Heideman BE; Kammer MN; Paez R; Swanson T; Godfrey CM; Low SW; Xiao D; Li TZ; Richardson JR; Knight MA; Shojaee S; Deppen SA; Lentz RJ; Grogan EL; Maldonado F
    CHEST Pulm; 2024 Mar; 2(1):. PubMed ID: 38737731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
    Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
    Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults.
    Yang B; Jhun BW; Shin SH; Jeong BH; Um SW; Zo JI; Lee HY; Sohn I; Kim H; Kwon OJ; Lee K
    PLoS One; 2018; 13(7):e0201242. PubMed ID: 30063725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Veterans Affairs, Mayo, Brock classification models and radiologist diagnosis for classifying the malignancy of pulmonary nodules in Chinese clinical population.
    Cui X; Heuvelmans MA; Han D; Zhao Y; Fan S; Zheng S; Sidorenkov G; Groen HJM; Dorrius MD; Oudkerk M; de Bock GH; Vliegenthart R; Ye Z
    Transl Lung Cancer Res; 2019 Oct; 8(5):605-613. PubMed ID: 31737497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Brock University, Mayo Clinic and Herder models for pretest probability of cancer in solid pulmonary nodules.
    Susam S; Çinkooğlu A; Ceylan KC; Gürsoy S; Kömürcüoğlu BE; Mertoğlu A; Çırak AK; Gayaf M; Güldaval F; Tuksavul F; Polat G; Ataman S; Yıldırım E; Koparal H; Yücel N
    Clin Respir J; 2022 Nov; 16(11):740-749. PubMed ID: 36207775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Thoracic Research Evaluation and Treatment 2.0 Model: A Lung Cancer Prediction Model for Indeterminate Nodules Referred for Specialist Evaluation.
    Godfrey CM; Shipe ME; Welty VF; Maiga AW; Aldrich MC; Montgomery C; Crockett J; Vaszar LT; Regis S; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Maldonado F; Blume JD; Deppen SA; Grogan EL
    Chest; 2023 Nov; 164(5):1305-1314. PubMed ID: 37421973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
    AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.
    Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK
    Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
    Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
    JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules.
    Peters AA; Weinheimer O; von Stackelberg O; Kroschke J; Piskorski L; Debic M; Schlamp K; Welzel L; Pohl M; Christe A; Ebner L; Kauczor HU; Heußel CP; Wielpütz MO
    Eur Radiol; 2023 Jun; 33(6):3908-3917. PubMed ID: 36538071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
    Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of pulmonary nodule risk scoring systems in Turkish population.
    Nomenoğlu H; Fındık G; Çetin M; Aydoğdu K; Gülhan SŞE; Bıçakçıoğlu P
    Updates Surg; 2024 Dec; 76(8):2903-2915. PubMed ID: 38944649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prediction model to evaluate the pretest risk of malignancy in solitary pulmonary nodules: evidence from a large Chinese southwestern population.
    Wu Z; Huang T; Zhang S; Cheng D; Li W; Chen B
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):275-285. PubMed ID: 33025281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
    Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
    Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment of malignancy in solitary pulmonary nodules in lung computed tomography: a multivariable predictive model study.
    Liu HY; Zhao XR; Chi M; Cheng XS; Wang ZQ; Xu ZW; Li YL; Yang R; Wu YJ; Zhang XJ
    Chin Med J (Engl); 2021 Jun; 134(14):1687-1694. PubMed ID: 34397595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy risk estimation of pulmonary nodules in screening CTs: Comparison between a computer model and human observers.
    van Riel SJ; Ciompi F; Winkler Wille MM; Dirksen A; Lam S; Scholten ET; Rossi SE; Sverzellati N; Naqibullah M; Wittenberg R; Hovinga-de Boer MC; Snoeren M; Peters-Bax L; Mets O; Brink M; Prokop M; Schaefer-Prokop C; van Ginneken B
    PLoS One; 2017; 12(11):e0185032. PubMed ID: 29121063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A radiomics-based decision support tool improves lung cancer diagnosis in combination with the Herder score in large lung nodules.
    Hunter B; Chen M; Ratnakumar P; Alemu E; Logan A; Linton-Reid K; Tong D; Senthivel N; Bhamani A; Bloch S; Kemp SV; Boddy L; Jain S; Gareeboo S; Rawal B; Doran S; Navani N; Nair A; Bunce C; Kaye S; Blackledge M; Aboagye EO; Devaraj A; Lee RW
    EBioMedicine; 2022 Dec; 86():104344. PubMed ID: 36370635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in VA and Non-VA Pulmonary Nodules: All Evaluations Are not Created Equal.
    New ML; Hirsch EA; Feser WJ; Malkoski SP; Garg K; Miller YE; Baron AE
    Clin Lung Cancer; 2023 Jul; 24(5):407-414. PubMed ID: 37012147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Benign and Malignant Pulmonary Ground-Glass Nodules Using Computed Tomography Radiomics Parameters.
    Liang L; Zhang H; Lei H; Zhou H; Wu Y; Shen J
    Technol Cancer Res Treat; 2022; 21():15330338221119748. PubMed ID: 36259167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.